Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Novartis
Business & Industry News Channel
Novartis
BioNTech
Roche
In comparison to the existing Roche SARS-CoV-2 Rapid Antigen Test, the SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, resulting in a simplified and faster testing procedure(1).
GlaxoSmithKline
AstraZeneca
Russian Direct Investment Fund (RDIF)
Bayer